论文部分内容阅读
病毒性肝炎是一个世界性的公共卫生问题,因此也是世界卫生组织(WHO)关于传染病预防和控制计划中,病毒性疾病科应承担的主要职责之一。乙型肝炎抗原发现后不久,WHO就推动了此领域的迅速进展,此工作计划包括两个主要方面:首先是通过科学小组及专家委员会就主要科学家已取得一致意见的最近重要发现提供给科学组织;其二,促进这些发现在国际上的应用。一、病毒性肝炎的进展 WHO作用之一是对不同技术的敏感性作出评价,这些技术在检测乙型肝炎抗原及其相应的抗血清方面(表一)已取得迅速的发展。提出统一的命名法也很重要。这是由一个科学小组[见WHO技术报告辑NO.512,日内瓦(1973)],一个会议[见WHO技术报告辑NO.570,日内瓦(1975)]及一个专家委员会[见WHO技术报告辑NO.602,日内
Viral hepatitis is a worldwide public health issue and therefore one of the main responsibilities that the World Health Organization (WHO) should bear in the Viral Diseases Section of the Program for the Prevention and Control of Infectious Diseases. Shortly after the discovery of hepatitis B antigens, the WHO has spurred rapid advances in this area. The work plan has two main components: first, through scientific panels and expert committees, scientific organizations on the most important findings that leading scientists have agreed to ; Second, to promote the international application of these findings. First, the progress of viral hepatitis One of WHO’s role is to evaluate the sensitivity of different technologies, these technologies in the detection of hepatitis B antigen and its corresponding antiserum (Table 1) has made rapid development. It is also important to propose a uniform nomenclature. This was led by a scientific panel [see WHO Technical Report No. 512, Geneva (1973)], a conference [see WHO Technical Report No. 570, Geneva (1975)] and a committee of experts [see WHO Technical Report No. .602, days